Further, our data indicate that modification of EGFR by palmitoylation influences its cellular distribution, particularly favoring its nuclear translocation in TKI‐resistant EGFR mutated NSCLC cells. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.